Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

NCT04573231 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-negative Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: 18F-DCFPyL

Sponsor

University of Wisconsin, Madison